// App-Quantinova.ai

: Determinants of survival in the European Bronchiectasis Registry(EMBARC)

Researchers

Presenter

  • Stefano Aliberti

Principal Investigators

  • Francesco Blasi

  • Felix Ringshausen

  • Anthony De Soyza

  • Montse Vendrell

  • Pieter Goeminne

  • Eva Polverino

  • Wim Boersma

  • Charles Haworth

  • Marlne Murris

  • Katerina Dimakou

  • Adam T Hill

  • Michael R Loebinger

  • Antoni Torres

  • Tobias Welte

  • R Wilson

  • Stuart Elborn

  • James D Chalmers

Medical Centers

  • Neurosurgery Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

  • Pneumology Department, Hospital Universitario y Politécnico La Fe / Instituto de Investigación Sanitaria (IIS) La Fe, Universidad de Valencia, Valencia, Spain

  • Neurosurgery Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

  • Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

  • Institute of Cellular Medicine, Newcastle University, Bronchiectasis Service, Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Bronchiectasis Group, IDIBGI, CIBERES, Dr Trueta University Hospital, Girona, Spain

  • Department of Respiratory Disease, AZ Nikolaas, Sint-Niklaas, Belgium; Department of Respiratory Disease, UZ Leuven, Leuven, Belgium

  • Respiratory Disease Dept, Hospital Universitari Vall d’Hebron (HUVH) Institut de Recerca Vall d’Hebron (VHIR) Passeig Vall d’Hebron, CIBERES, Barcelona, Spain

  • Department of Pulmonary Diseases, Medical Center Alkmaar, Alkmaar, Netherlands

  • Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, United Kingdom

  • Service de pneumologie, Hopital Larrey, CHU Toulouse, Toulouse, France

  • 2nd Pulmonary Department Sotiria Hospital, ATHENS, Greece

  • Respiratory Medicine, Royal Infirmary of Edinburgh, and University of Edinburgh, Edinburgh, United Kingdom

  • Host Defence Unit, Royal Brompton Hospital, London, UK and National Heart and Lung Institute, Imperial College, London, United Kingdom

  • Pneumology Dept, Hospital CLINIC, University of Barcelona, IDIBAPS, CIBERE, Barcelona, Spain

  • Host Defence Unit, Department of Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

  • Royal Brompton Hospital and Imperial College London, and Queens University Belfast, London, United Kingdom

  • University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom

Locations

  • Italy

  • Spain

  • Germany

  • United Kingdom

  • Belgium

  • Netherlands

  • France

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Rheumatoid arthritis

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved